Paul K. Wotton, President and CEO at ANTARES PHARMA, INC. (AIS), bought 20,000 shares at $0.41 ($8K) on 2009-03-30, disclosed to the SEC on 2009-03-31.
Open-market purchase of $8k AIS by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.40 | 10,000 | $4K | 49.4% |
| 2 | $0.41 | 10,000 | $4K | 50.6% |
| Total | $0.41 avg | 20,000 | $8K | 100% |
| Filing → |
| VCEL | SELL | 2024-12-05 | $153K | — | Filing → |
| VCEL | SELL | 2023-12-15 | $187K | — | Filing → |
| VCEL | SELL | 2021-05-17 | $505K | — | Filing → |